E-LIB Suche - Ergebnisse für: Garfall, Alfred L.

1

Exploiting the CD200-CD200R immune checkpoint axis in multi..:

Tang, Yan ; Liu, Wei ; Kadu, Siddhant...
Blood. 143 (2024) 2 - p. 139-151 , 2024

Link: https://doi.org/10.1182/..

2

Bendamustine lymphodepletion before axicabtagene ciloleucel..:

Ghilardi, Guido ; Paruzzo, Luca ; Svoboda, Jakub...
Blood Advances. 8 (2024) 3 - p. 653-666 , 2024

Link: https://doi.org/10.1182/..

3

Efficacy and safety of bendamustine for lymphodepletion bef..:

Ghilardi, Guido ; Paruzzo, Luca ; Patel, Vrutti...
Journal of Hematology & Oncology. 17 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

4

Teclistamab Improves Patient-Reported Symptoms and Health-R..:

Martin, Thomas G. ; Moreau, Philippe ; Usmani, Saad Z....
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 3 - p. 194-202 , 2024

Link: https://doi.org/10.1016/..

5

Bendamustine as Lymphodepletion for Brexucabtagene Autoleuc..:

Chong, Elise A. ; Chong, Emeline R. ; Therwhanger, Dylan...
Transplantation and Cellular Therapy. , 2024

Link: https://doi.org/10.1016/..

6

Clinical Management of Patients With Relapsed/Refractory Mu..:

Chari, Ajai ; Krishnan, Amrita ; Rasche, Leo...
Clinical Lymphoma Myeloma and Leukemia. , 2024

Link: https://doi.org/10.1016/..

7

New Biological Therapies for Multiple Myeloma:

Garfall, Alfred L.
Annual Review of Medicine. 75 (2024) 1 - p. 13-29 , 2024

Link: https://doi.org/10.1146/..

8

T cell lymphoma and secondary primary malignancy risk after..:

Ghilardi, Guido ; Fraietta, Joseph A. ; Gerson, James N....
Nature Medicine. 30 (2024) 4 - p. 984-989 , 2024

Link: https://doi.org/10.1038/..

9

Human IL-6 fosters long-term engraftment of patient-derived..:

Hasanali, Zainul S. ; Garfall, Alfred L. ; Burzenski, Lisa...
JCI Insight. 9 (2024) 10 - p. , 2024

Link: https://doi.org/10.1172/..

10

P911: EVALUATION OF PROPHYLACTIC TOCILIZUMAB (TOCI) FOR THE..:

van de Donk, Niels W.C.J. ; Garfall, Alfred ; Benboubker, Lotfi...
HemaSphere. 7 (2023) S3 - p. e43149cb , 2023

Link: https://doi.org/10.1097/..

11

MM-163 Long-Term Follow-Up From MajesTEC-1 of Teclistamab, ..:

van de Donk, Niels ; Moreau, Philippe ; Garfall, Alfred...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S477-S478 , 2023

Link: https://doi.org/10.1016/..

12

P881: DURABILITY OF RESPONSES WITH BIWEEKLY DOSING OF TECLI..:

Bhutani, Manisha ; Garfall, Alfred ; Uttervall, Katarina...
HemaSphere. 7 (2023) S3 - p. e90600b0 , 2023

Link: https://doi.org/10.1097/..

13

Survival Outcomes for Patients with Relapsed/ Refractory Ag..:

Landsburg, Daniel J. ; Nasta, Sunita D. ; Svoboda, Jakub...
Transplantation and Cellular Therapy. 29 (2023) 8 - p. 495-503 , 2023

Link: https://doi.org/10.1016/..

14

P879: LONG-TERM FOLLOW-UP FROM MAJESTEC-1 OF TECLISTAMAB, A..:

Sidana, Surbhi ; Moreau, Philippe ; Garfall, Alfred...
HemaSphere. 7 (2023) S3 - p. e62475d0 , 2023

Link: https://doi.org/10.1097/..

15

Population Pharmacokinetics and Exposure–Response with Tecl..:

Miao, Xin ; Wu, Liviawati S. ; Lin, Shun Xin Wang...
Targeted Oncology. 18 (2023) 5 - p. 667-684 , 2023

Link: https://doi.org/10.1007/..